IMATINIB

100 Milligram Film Coated Tablet

Fresenius Kabi Deutschland GmbHPA2059/002/001

Main Information

Trade NameIMATINIB
Active SubstancesIMATINIB MESILATE
Strength100 Milligram
Dosage FormFilm Coated Tablet
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/002/001

Group Information

ATC CodeL01XE01 Protein kinase inhibitors

Status

Authorised/WithdrawnAuthorised
Licence Issued08/04/2016
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.